Genome Medical scoops up telegenetic counseling platform GeneMatters, raises $60M in Series C

Genome Medical scoops up telegenetic counseling platform GeneMatters, raises $60M in Series C

The company plans to use the new cash to build its staff and grow its services.

This morning Genome Medical, a health tech company that provides genetic insights and services to clients, announced the acquisition of telegenetic counseling platform GeneMatters. 

The announcement coincides with the news of Genome Medical’s $60 million Series C funding round led by Casdin Capital with participation from GV, Amgen Ventures and existing investors. 

Genome Medical plans to use the infusion of cash to build out its team and continue to grow its physician services, test ordering capabilities and guideline-based care plans. 


Deploy this technology today



Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Mar 28, 2024 at 3:00am